Embecta Corp. (EMBC) Revenue History
Embecta Corp. (EMBC) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2022-09-30 | $1.13B |
| 2023-09-30 | $1.12B |
| 2024-09-30 | $1.12B |
| 2025-09-30 | $1.08B |
How EMBC compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| ARRY | Array Technologies Inc. | $1.28B |
| NVAX | Novavax Inc. | $1.12B |
| IONS | Ionis Pharmaceuticals Inc. | $943.71M |
| BCRX | BioCryst Pharmaceuticals Inc. | $874.84M |
| NEOG | Neogen Corporation | $870.40M |
These are five companies in the same sector as EMBC with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Embecta Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("EMBC", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | EMBC | $5.42 | +6.27% | 1.26M |
| 3 | ||||
| 4 | ||||
| 5 |